Sinovac Phase 3 Trial Results Expected Next Week

"); jQuery("#212 h3").html("

Related News Programmes

"); jQuery(document).ready(function() { jwplayer.key='EKOtdBrvhiKxeOU807UIF56TaHWapYjKnFiG7ipl3gw='; var playerInstance = jwplayer("jquery_jwplayer_1"); playerInstance.setup({ file: "https://newsstatic.rthk.hk/audios/mfile_1565715_1_20201217054113.mp3", skin: { url: location.href.split('/', 4).join('/') + '/jwplayer/skin/rthk/five.css', name: 'five' }, hlshtml: true, width: "100%", height: 30, wmode: 'transparent', primary: navigator.userAgent.indexOf("Trident")>-1 ? "flash" : "html5", events: { onPlay: function(event) { dcsMultiTrack('DCS.dcsuri', 'https://news.rthk.hk/rthk/en/component/k2/1565715-20201217.mp3', 'WT.ti', ' Audio at newsfeed', 'WT.cg_n', '#rthknews', 'WT.cg_s', 'Multimedia','WT.es','https://news.rthk.hk/rthk/en/component/k2/1565715-20201217.htm', 'DCS.dcsqry', '' ); } } }); }); });

2020-12-17 HKT 05:38

Share this story

facebook

  • The government announced last week that it has secured 7.5 million doses from the mainland firm. Photo: Shutterstock

    The government announced last week that it has secured 7.5 million doses from the mainland firm. Photo: Shutterstock

Government adviser and respiratory medicine expert Dr David Hui said on Wednesday that he expected the phase 3 clinical trial results of the Sinovac coronavirus vaccine to be out on December 23.

The government announced last week that it had secured 7.5 million doses from the mainland firm as part of its procurement programme.

Dr Hui said if there were no problems with the trial results, the vaccine could be introduced here next month.

"At the moment Sinovac has published phase 1 and phase 2 data, showing the antibodies can develop in over 90 percent of the recipients," he said.

Dr Hui said that only when the company had good data would the vaccine be introduced in Hong Kong.

The government is making arrangements for three vaccines: Sinovac, Fosun BioNTech and Astrazeneca.

Dr Hui said the public wouldn't get to choose which vaccine they would get because this could lead to a shortage of one type of vaccine and a surplus of another.

He said any vaccine that was in surplus might therefore end up being wasted, as they have a shelf-life of about six months.

RECENT NEWS

Vietnam And South Korea Launch Cross-Border QR Payments

Vietnam and South Korea have launched cross-border QR payments that allow Korean users to pay merchants in Vietnam thro... Read more

WeChat Pay Integrates With Local QR Networks In 5 Asian Countries

WeChat Pay has integrated its service with national QR code networks in five Asian countries, simplifying cross-border ... Read more

Global Transition Finance Ecosystem Gains Momentum

The global transition finance ecosystem is gaining momentum. According to new research by the Hong Kong Institute for M... Read more

Banking Circle Taps PayGate To Ease KRW Cross-Border Payments Into South Korea

Global payments bank Banking Circle will now handle cross-border transactions and settlement flows for South Korean pay... Read more

Equinix AI Discovery Hub Opens In Hong Kong For Enterprise AI

Digital infrastructure company Equinix is partnering with Hewlett Packard Enterprise (HPE) to launch the Equinix AI Dis... Read more

Tencent, Alibaba Eye DeepSeek Stake As AI Startup Tops US$20B Valuation

Chinese tech giants Tencent and Alibaba are in discussions to invest in AI startup DeepSeek, The Information reported, ... Read more